Oral health and saliva bacteria in children with juvenile idiopathic arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at how oral health and mouth bacteria relate to disease activity in children with juvenile idiopathic arthritis (JIA). If your child has JIA, participating could help doctors understand more about the condition and may guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 16 years old.
- Your child must have a diagnosis of juvenile idiopathic arthritis (JIA), but not the systemic-onset type.
- Your child must either have active arthritis with a plan to start or adjust medication within a month, or be in remission with stable disease.
- Your child must be able to cooperate with an oral exam and saliva sample collection.
- A parent or guardian must provide consent, and the child must agree to participate.
- Your child must not have used antibiotics in the last 3 months, or certain mouthwashes in the last month, and must not have other conditions like diabetes or heart disease.
- Your child must not have an active infection or dental braces or planned braces in the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain blood markers relate to disease activity in children with juvenile idiopathic arthritis (JIA). It aims to help doctors better understand and track the condition, which could lead to improved care.
This trial tests whether a special diet can help children and teens with juvenile arthritis. If you join, you will follow the diet and provide stool samples so the researchers can see how it affects your gut and arthritis.
This study looks at children with arthritis to better understand their condition using clinical exams, lab tests, and ultrasounds. It may help doctors learn more about different types of juvenile arthritis.
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
This study creates a personalized medicine network to better understand and treat childhood arthritis. If you have JIA or unexplained joint inflammation, researchers will look at your biology to find the best treatment approach for you.
This trial studies sarilumab, a targeted medicine, to help reduce symptoms in children and teens with systemic juvenile idiopathic arthritis (sJIA) who have not responded enough to current treatments. You may be considered because the study looks at how well and safely repeated doses work in pediatric patients.
Hear when a new Juvenile Idiopathic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.